Update on Early-Onset Colorectal Cancer (EOCRC)
Thomas F. Imperiale, MDIndiana University School of Medicine
Indianapolis, IN, USAWEO Colorectal Cancer Screening (Virtual) Committee Meeting
October 9, 2020
Outline for this talk*
• Review basic epidemiology of EOCRC
• Discuss recent studies on genetic and phenotypic risk factors
– Includes risk prediction models
• Discuss what’s needed and what can be done now
*No relevant disclosures
Siegel RK, et al. Gut 2019
Age-standardized incidence rates, 2008-12, for CRC, adults 20-49 years:- Red – AAPC increased- Gray – stable or insufficient numbers- Blue – AAPC decreased
Siegel RL, et al. Gut 2019; 68:2179-85
Epidemiology of EOCRC (U.S.)• 10-11% of all CRC
• Median age = 44 years
• 75% of all EOCRC occurs in 40-49 year-olds– 50% of all in 45-49 year-olds
• 75% of EOCRC is distal to the splenic flexure
• 17% have a FDR w/ CRC (vs. 8% controls)
• 15% have deficient MMR activityPatel SG and Boland CR. Gastrointest Endoscopy Clin N Am 2020:30:441-455
0
10
20
30
40
50
60
70
80
90
100
20 25 30 35 40 45 50 55 60 70 80
Genetic Risk Phenotypic Risk
Contributors to CRC Risk
Study Aim and Methods• Determine whether a “personalized risk score” (PRS) of 95 CRC
associated SNPs is associated with EOCRC• Pooled CRC cases and controls with clinical and genotyping data
– Colon Cancer Family Registry– Colorectal Transdisciplinary Study– Genetics and Epidemiology of CRC Consortium (GECCO)
• Weighed PRS based on # risk alleles for each SNP• Compared PRS between EOCRC & Late-onset CRC, and between
cases and controls• Findings tested in replication dataset of 72,573
– 25 EOCRC, 1,068 Usual-onset CRC, 71,380 controls w/o CRC
Risk estimates for EO vs Late-onset CRC associated with a 95-SNP PRS (Archambault et al. Gastroenterology 2020)
GROUPHazard Ratio (95% CI) per 1 Std deviation
P-value Fold-increase from lowest to highest quintile
All Subjects
< 50 years old 1.73 (1.17-2.56) 0.0056 3.7
≥ 50 years old 1.43 (1.34-1.51) 2.77E-31 2.9
Negative Family History
< 50 years old 1.76 (1.11-2.78) 0.0161 4.3
≥ 50 years old 1.42 (1.33-1.52) 2.85E-25 2.9
Positive Family History
< 50 years old 1.56 (0.75-3.26) 0.23 1.7
≥ 50 years old 1.34 (1.17-1.54) 2.87E-5 2.5
Archambault AN, et al. Gastroenterology 2020
Archambault AN, et al. Gastroenterology 2020
Study summary
• The PRS, derived from common SNPs, stratifies individuals for risk of EOCRC, particularly among those reporting no FDR with CRC.
• The associations between PRS and CRC are greater for EOCRC than for late-onset CRC.
• The PRS may – along with lifestyle and environmental risk factors – contribute toward prioritizing earlier, personalized screening or other interventions.
Selected recent studies on RFs for EO-CRCCountry, yr
Study design Study N Age Group
Outcome (%) Independent Risk Factors
S. Korea, 2017
Prospective XS, screening colonoscopy
2206 40-49 Adv Neoplasia (2.4)
Age (1.16), smoking (3.12) metabolic syndrome (2.00)
China, 2017
Prospective XS, screening colonoscopy
1133 40-49 Adv Neoplasia (2.9)
Male sex, age 45-49, FDR w/CRC, (NNS=18.5) with all 3; diabetes
UK, 2019 Case-control (Clin Practice Research Datalink)
29K cases137K con.
< 50 CRC Penicillin (1.5), Tetracycline (0.90) Atbx use > 10 years prior (1.17)
U.S., 2019
Prospective cohort (Nurses Health Study II)
89,278 women 118 EOCRC
25-42 CRC > 14 hours of TV/wk (vs. ≤ 7 hrs) RR=1.69; RR=2.44 for rectal CA, no FHx
U.S., 2020
Case-control (single center)
269 EOCRC2802 LO-CRC1122 controls
18-49 CRC Male sex, IBD, FHx of CRC – risk factors for EOCRC vs. controls; Male, Black, Asian, IBD, FHx for EOCRC vs LOCRC
Koo JE, J Gastro Hep 2017; 32:98-105; Wong JTC, J Gastro Hep 2017; 32:92-97; Gausman V, Clin Gastro Hep 2019; Zhang J, et al. Gut 2019; doi:10.1136/gutjnl-2019-318593; Nguyen LH, JNCI Cancer Spectrum 2019; 2(4);pky073
Prevalence of Self-Reported Obesity Among U.S. Adults by State and Territory, BRFSS, 2019
BMI at an early age and risk of CRC• Meta-analysis of 15 observational studies
– 13 cohort, 2 case-control
• Related body “fatness” prior to age 30 to current risk of CRC - per 5 kg/m2 increase
• Covariates – age, sex, SES, education, physical activity, diet components, smoking, alcohol, OC/exogenous estrogens, FHx CRC, Ht, DM, ASA
Hidayat K, et al. Int’l J Cancer 2018; 142:729-740
Subgroup of studies for persons < 50 years
1st Author Design N Meanage (years)
F/U duration (years)
Adjusted Relative Risk* (95% CI)
Lundqvist Pro cohort 25,565 28.4 28.4 (!) 1.07 (0.98-1.17)
Burton Retro cohort 12,206 20 49 1.16 (0.90-1.50)
Levi Pro cohort 1.1 million 17.3 17.6 1.21 (1.00-1.45)
Kantor Pro cohort 239,658 18 35 1.29 (1.17-1.42)
Hidayat K, et al. IJC 2018
* Per 5 kg/m2 increase
RISK PREDICTION MODELS FOR ADVANCED COLORECTAL NEOPLASIA IN PERSONS < 50
1ST Au, Country, Year
Population(N)
Model variables
Advanced neoplasia (%)
How the model was used
Model metrics and Results
Jung YS, S. Korea, 2017
30-49 year olds, screening colonoscopyN=57,635 derivationN=38,600 validation
Age, sex, BMI, FHx CRC, smoking
1.2 % Cutoff of >= 1.4% predicted probability
AUROC = 0.67 vs. APCS at 0.59, KCS at 0.60, and Kaminski at 0.59
Park YM S. Korea, 2017
40-49 year olds, screening colonoscopyN=2,781
“Older” age (45-49) years, male sex, HDL chol, H. pylori, triglycerides.
2.5% Scoring system of 0 →9; score of ≥ 4 as “high risk” (43%)
“High-risk” had Sensitivity =79%Specificity = 58%AUROC = 0.72
Jung, YS, et al. Dig Dis Sci 2017;62:2518-25 Park YM, et al. BMC Gastro 2017; 17:7
What is needed• Hypothesis-generating research
– Population-based (“ecological”) research – identify candidate risk factors
– Lab-based research on cellular / molecular mechanisms
• Observational research – identify / solidify risk factors– Improve risk stratification (?combine with genetic RFs)
• Large database research examining gene-environment interactions– Consider microbiome
• Promotion of what we can do NOW……
What to do now for EOCRC
• For patients / the public– Report lower GI symptoms, especially bleeding– Look at stools, toilet paper– Adhere to healthy lifestyle – diet, BMI, exercise, no smoking, limit ethanol
• For providers– Take thorough family histories – other cancers, AAs– *ASK* re: lower GI symptoms, constitutional (unintended weight loss)– At least sigmoidoscopy for unexplained rectal bleeding– Appropriate use of colonoscopy (e.g., unexplained Fe-deficient anemia) – Appropriate imaging for unexplained abdominal pain– Consider “early” screening (45) for multiple risk factors (smoking, BMI)
• For systems– Universal testing of CRCs for dMMR (and NGS for all EOCRC)
Thomas F. Imperiale, MD